Brain Cancer Medicines: Generic Glioblastoma & Brain Tumor Treatments
Brain cancer, including glioblastoma multiforme (GBM), is a serious malignancy affecting the central nervous system. OnlineMeds provides FDA-approved generic medications used as adjunctive and maintenance therapy for high-grade gliomas—at up to 90% savings compared to branded versions. Our portfolio includes supportive care medications alongside specialized agents.
Our Brain Cancer Treatment Options
- Temozolomide (Temodar) — Alkylating agent standard for glioblastoma
- Bevacizumab (Avastin) — Anti-angiogenic antibody for recurrent GBM (specialty order)
- Irinotecan (Camptosar) — Chemotherapy for recurrent glioblastoma
- Dexamethasone — Corticosteroid for brain edema management
- Lamotrigine / Levetiracetam — Seizure prophylaxis (common in brain cancer)
- Supportive medications — Antiemetics, gastroprotectants, and pain management
How These Medicines Work
Temozolomide is the alkylating agent standard of care for glioblastoma, crossing the blood-brain barrier to target tumor cells. Bevacizumab targets VEGF to reduce tumor angiogenesis in recurrent disease. Dexamethasone reduces vasogenic edema around tumors. Anti-seizure medications prevent seizures common in brain cancer patients. Multimodal therapy (surgery + radiation + chemotherapy) remains the standard approach.
Why Choose OnlineMeds for Brain Cancer Medicines?
- FDA-approved generic Temozolomide at 90% savings vs. Temodar
- Full range of supportive and adjunctive medications
- Prescription verification and clinical review
- Reliable international shipping
- Patient education materials and pharmacy support
Frequently Asked Questions
Q: What is the standard treatment for glioblastoma?
A: The Stupp protocol (maximal surgical resection + concurrent chemoradiation with temozolomide + adjuvant temozolomide) is the standard of care. This is established treatment—your neuro-oncologist will adapt for your specific case. This content is for educational purposes only.
Q: How is temozolomide dosed?
A: During concurrent chemoradiation, temozolomide is 75 mg/m² daily. Adjuvant therapy uses 150–200 mg/m² for 5 days of 28-day cycles. Your oncology team will calculate your exact dose.
Q: What side effects should I expect?
A: Nausea, vomiting, fatigue, low blood counts (especially thrombocytopenia), and liver enzyme elevations are common. Seizures may occur independent of chemotherapy. Your team will manage side effects closely.
Q: Can I take temozolomide if I’m also receiving radiation?
A: Yes. Concurrent chemoradiation with temozolomide is standard. However, this is complex therapy requiring coordination between your neurosurgeon, radiation oncologist, and medical oncologist.
Q: What happens if glioblastoma recurs after initial treatment?
A: Options include repeat surgery, re-irradiation, and chemotherapy (irinotecan, bevacizumab). Some patients may be eligible for clinical trials. Discuss options urgently with your neuro-oncology team.
Q: Are there seizure prevention medications I should take?
A: Seizures occur in 20–40% of glioblastoma patients. Levetiracetam or lamotrigine are common choices for prophylaxis. Your neurologist will determine if prevention is appropriate for you.
Medical Disclaimer
This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Glioblastoma is a life-threatening disease requiring urgent, specialized care from a multidisciplinary neuro-oncology team. Always use brain cancer medicines exactly as prescribed by a licensed neuro-oncologist or medical oncologist. In case of seizures, stroke symptoms, severe headache, or other emergencies, seek immediate emergency care. If you have questions about your treatment plan, contact your oncology team immediately.